The Korean Hereditary Breast Cancer Study: Review and Future Perspectives

다국어 초록 (Multilingual Abstract)

Most studies related to BRCA mutations have been performed in Western populations, and only a few small studies have been conducted in Korean populations. In 2007, the Korean Hereditary Breast Cancer (KOHBRA) Study was established to obtain evidence for the accurate risk assessment and management of hereditary breast and ovarian cancer (HBOC) in Korea. Between May 2007 and May 2010, the first phase of the KOHBRA Study was performed to estimate the prevalence of BRCA1/2 mutations among patients and their families at risk for HBOC. Between June 2010 and May 2013, the second phase of the KOHBRA Study was performed to identify the clinical characteristics and prognostic indicators of BRCA-related breast cancer and environmental and genetic modifiers of BRCA mutations and to develop a Korean BRCA risk calculator and nationwide genetic counseling network for HBOC. Herein, we review the results of the KOHBRA Study and describe the future perspectives of the study.

참고문헌 (Reference)

1 구도훈, "한국인BRCA 돌연변이 보인자 여성의 암 발생 감시, 화학적 예방 및 예방적 수술 사용 실태: 단일 기관의 5년간 경험" 한국유방암학회 14 : 17-23, 2011

2 김성원, "한국인 유전성 유방암 연구 이후 국내 유전성 유방암 진료 패턴의 변화" 한국유방암학회 13 (13): 418-430, 2010

3 강은영, "한국인 유전성 유방암 가계에서 BRCA1/2 유전자 돌연변이 사실에 대한 가족과의 의사소통 실태" 대한의학유전학회 8 (8): 105-112, 2011

4 김구상, "‘한국인 유전성유방암의 진료현황’에 대한 설문조사결과" 한국유방암학회 11 (11): 95-101, 2008

5 Evans DG, "Update on the Manchester Scoring System for BRCA1 and BRCA2 testing" 42 : 39-, 2005

6 Han SA, "The prevalence of BRCA mutations among familial breast cancer patients in Korea : results of the Korean Hereditary Breast Cancer study" 12 : 75-81, 2013

7 Claus EB, "The genetic attributable risk of breast and ovarian cancer" 77 : 2318-2324, 1996

8 Stratton MR, "The emerging landscape of breast cancer susceptibility" 40 : 17-22, 2008

9 Han SA, "The Korean Hereditary Breast Cancer(KOHBRA)study : protocols and interim report" 23 : 434-441, 2011

10 Antoniou AC, "The BOADICEA model of genetic susceptibility to breast and ovarian cancer" 91 : 1580-1590, 2004

11 El-Tamer M, "Survival and recurrence after breast cancer in BRCA1/2 mutation carriers" 11 : 157-164, 2004

12 Stirling D, "Screening for familial ovarian cancer : failure of current protocols to detect ovarian cancer at an early stage according to the International Federation of Gynecology and Obstetrics system" 23 : 5588-5596, 2005

13 Rebbeck TR, "Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations" 346 : 1616-1622, 2002

14 Son BH, "Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea : the Korean Hereditary Breast Cancer(KOHBRA)Study" 133 : 1143-1152, 2012

15 Berliner JL, "Practice Issues Subcommittee of the National Society of Genetic Counselors’ Familial Cancer Risk Counseling Special Interest Group. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors" 16 : 241-260, 2007

16 Kurian AW, "Performance of BRCA1/2 mutation prediction models in Asian Americans" 26 : 4752-4758, 2008

17 Chen S, "Meta-analysis of BRCA1 and BRCA2 penetrance" 25 : 1329-1333, 2007

18 Korean Breast Cancer Society, "Manual for Hereditary Breast Cancer Counseling" Koonja 2012

19 Wooster R, "Identification of the breast cancer susceptibility gene BRCA2" 378 : 789-792, 1995

20 Korean Hereditary Breast Cancer Study Group ; Korean Breast Cancer Society, "Hereditary Breast Cancer" Koonja 2012

21 Jemal A, "Global cancer statistics" 61 : 69-90, 2011

22 Oh JH, "Germline mutation of BRCA1 gene in Korean breast and ovarian cancer patients" 27 : 1061-1070, 1995

23 Long J, "Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer" 8 : 1002532-, 2012

24 "Genetic/familial high-risk assessment: breast and ovarian" National Comprehensive Cancer Network

25 Stoppa-Lyonnet D, "Familial invasive breast cancers : worse outcome related to BRCA1 mutations" 18 : 4053-4059, 2000

26 Kim D, "Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation" 2013

27 Lee EH, "Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival : a systematic review and meta-analysis" 122 : 11-25, 2010

28 Parmigiani G, "Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2" 62 : 145-158, 1998

29 Seong MW, "Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients : evidence of a founder mutation" 76 : 152-160, 2009

30 Zheng W, "Common genetic determinants of breast-cancer risk in East Asian women : a collaborative study of 23 637 breast cancer cases and 25 579 controls" 22 : 2539-2550, 2013

31 Rennert G, "Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations" 357 : 115-123, 2007

32 Frank TS, "Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals" 20 : 1480-1490, 2002

33 Kim H, "Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer" 134 : 1315-1326, 2012

34 Kyu-Won Jung, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009" 대한암학회 44 (44): 11-24, 2012

35 Fackenthal JD, "Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations" 7 : 937-948, 2007

36 이정언, "BRCA2 돌연변이 보인자의 양측성 예방적 유방절제술에서 우연히 발견된 유관 상피내암 1예" 한국유방암학회 13 (13): 311-317, 2010

37 김구상, "BRCA1 유전자 돌연변이가 있는 유방암 환자에서 시행한예방적반대편유방절제술및난소절제술1예" 한국유방암학회 11 (11): 218-222, 2008

38 한상아, "BRCA1 및BRCA2 유전자 돌연변이에 기인한 한국인 유방암 및 난소암 위험도: 예비 연구 결과보고" 한국유방암학회 12 (12): 92-99, 2009

39 Nicoletto MO, "BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling" 127 : 295-304, 2001

40 Domchek SM, "Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality" 304 : 967-975, 2010

41 Kang E, "Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients" 134 : 1189-1197, 2012

42 Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al, "A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1" 266 : 66-71, 1994

43 Kim HC, "A genomewide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study" 14 : 56-, 2012

44 Robson ME, "A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment" 6 : 8-17, 2004